Progestin-only contraceptive rings

Steroids

Volumn 65, Issue 10-11, 2000, Pages 687-691

  Brache, Vivian ^a   Alvarez Sanchez, Francisco ^a   Faundes, Anibal ^b   Jackanicz, Theodore ^c   Mishell Jr , Daniel R ^d   Lähteenmäki, Pekka ^e  

^a PROFAMILIA   (Dominican Republic)

^b Center for Mother and Child Research of Campinas   (Brazil)

^c POPULATION COUNCIL   (United States)

^d WOMEN S AND CHILDREN S HOSPITAL   (United States)

^e UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Contraceptive ring; Levonorgestrel; Nestorone ; Ovulation; Progestin

Indexed keywords

ELCOMETRINE; GESTAGEN; LEVONORGESTREL; MEDROXYPROGESTERONE ACETATE;

ARTICLE; CLINICAL TRIAL; COITUS; CONTROLLED DRUG RELEASE; DOSE RESPONSE; HORMONAL CONTRACEPTION; HUMAN; MENSTRUATION DISORDER; OVULATION INHIBITION; PATIENT COMPLIANCE; PREGNANCY RATE; VAGINA CONTRACEPTION; VAGINA DISEASE;

ADMINISTRATION, INTRAVAGINAL; CONTRACEPTIVE AGENTS, FEMALE; DELAYED-ACTION PREPARATIONS; DRUG IMPLANTS; FEMALE; HUMANS; PREGNANCY; PROGESTINS;

EID: 0033663454     PISSN: 0039128X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0039-128X(00)00175-6     Document Type: Article

References (34)

1. Contraceptive failure rates in developing countries: Evidence from the Demographic and Health Surveys
2. Contraceptive failure rates based on the 1988 NSFG
3. Long-acting contraceptives: Ethical guidance for policymakers and health care providers
4. Contraceptive effect of varying dosages of progestogen in silastic vaginal rings
5. Basic studies for prolonged progestogen administration by vaginal devices
6. Plasma concentrations of a progestin R 2323 released from vaginal rings
7. The effect of progestin R 2323 released from vaginal rings on ovarian function
8. Initial clinical studies of intravaginal rings containing norethindrone and norgestrel
9. Vaginal progesterone for contraception
10. Pharmacokinetic and pharmacodynamic effects of small doses of norethisterone released from vaginal rings continuously during 90 days
11. Intravaginal contraception with the synthetic progestin, R2010
12. Pharmacokinetic observations on ST-1435 administered subcutaneously (s.c.) and intravaginally
13. Fertility regulation in nursing women: VIII. Progesterone plasma levels and contraceptive efficacy of a progesterone-releasing vaginal ring
14. Pharmacodynamics of a contraceptive vaginal ring releasing 3-keto-desogestrel
15. Evaluation of four different contraceptive vaginal rings: Steroid serum levels, luteal activity, bleeding control and lipid profiles
16. Contraceptives for lactating women: A comparative trial of a progesterone-releasing vaginal ring and the Copper T 380 A IUD
17. Task Force on Long-Acting Systemic Agents for Fertility Regulation Special Programme of Research Development and Research Training in Human Reproduction. Microdose intravaginal levonorgestrel contraception: A multicentre clinical trial. I. Contraceptive efficacy and side effects
18. Pharmacokinetic and pharmacodynamic investigations with vaginal devices releasing levonorgestrel at a constant, near zero order rate
19. Pharmacokinetic and pharmacodynamic studies of vaginal rings releasing low-dose levonorgestrel
20. A clinical pharmacological study of a new type of vaginal delivery system for levonorgestrel
21. Morphometric study of the human endometrium following continuous exposure to levonorgestrel released from vaginal rings during 90 days
22. Task Force on Long-Acting Systemic Agents for Fertility Regulation Special Programme of Research Development and Research Training in Human Reproduction. Microdose intravaginal levonorgestrel contraception: A multicentre clinical trial. III. The relationship between pregnancy rate and body weight
23. Task Force on Long-Acting Systemic Agents for Fertility Regulation Special Programme of Research Development and Research Training in Human Reproduction. Microdose intravaginal levonorgestrel contraception: A multicentre clinical trial. II. Expulsions and removals
24. Task Force on Long-Acting Systemic Agents for Fertility Regulation Special Programme of Research Development and Research Training in Human Reproduction. IV. Bleeding patterns
25. Preliminary report of unexpected local reactions to a progestogen-releasing contraceptive vaginal ring
26. Special Programme of Research, Development, and Research Training in Human Reproduction
27. Vaginal epithelial surface appearances in women using vaginal rings for contraception
28. Variations in vaginal epithelial surface appearance determined by colposcopic inspection in healthy, sexually active women
29. Progesterone implants enhance SIV vaginal transmission and early virus load
30. Effects of two progestin-only contraceptives, Depo-Provera and Norplant-II, on the vaginal epithelium of rhesus monkeys
31. The effect of one injection of Depo-Provera on the human vaginal epithelium and cervical ectopy
32. Acceptabiliity of the contraceptive vaginal ring by rural and urban population in two Latin America countries
33. The acceptability of a combined oestrogen/progestogen contraceptive vaginal ring
34. Women's perceptions and experience with the progesterone vaginal ring for contraception during breastfeeding